Name Net increased
positions
Increased positions Reduced positions Return since
31 Mar ‘18
776
2 2 0 3.53%
777
2 21 19 37.4%
778
2 5 3 36%
LXRX icon
779
Lexicon Pharmaceuticals
LXRX
$775M
2 40 38 80.4%
780
2 50 48 90.7%
781
2 12 10 32.4%
782
2 4 2 44.7%
783
2 64 62 48.1%
784
1 1 0 15.7%
785
1 2 1 19.9%
RFV icon
786
Invesco S&P MidCap 400 Pure Value ETF
RFV
$311M
1 10 9 109%
787
1 1 0 180%
788
1 2 1 47.4%
789
1 52 51 26.9%
790
1 3 2 56.6%
791
1 5 4 41.5%
792
1 23 22 53.3%
793
1 4 3 10.7%
794
1 34 33 26.6%
795
1 72 71 55.7%
796
1 20 19 158%
797
1 13 12 16.9%
798
1 3 2 2.03%
799
1 14 13 91.3%
800
1 1 0 182%